{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T18:03:25Z","timestamp":1767981805702,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Tehran University of Medical Sciences and health services","award":["95-01-27-30136"],"award-info":[{"award-number":["95-01-27-30136"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.virusres.2017.08.016","type":"journal-article","created":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T22:15:56Z","timestamp":1504304156000},"page":"207-214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Targeting human breast cancer cells by an oncolytic adenovirus using microRNA-targeting strategy"],"prefix":"10.1016","volume":"240","author":[{"given":"Mohammad","family":"Shayestehpour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharareh","family":"Moghim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vahid","family":"Salimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somayeh","family":"Jalilvand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jila","family":"Yavarian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bizhan","family":"Romani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talat","family":"Mokhtari-Azad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.virusres.2017.08.016_bib0005","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/nbt1208-1346","article-title":"MicroRNAs fine-tune oncolytic viruses","volume":"26","author":"Bell","year":"2008","journal-title":"Nat. Biotechnol."},{"issue":"9","key":"10.1016\/j.virusres.2017.08.016_bib0010","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1038\/mt.2014.98","article-title":"miR-148a-and miR-216a-regulated oncolytic adenoviruses targeting pancreatic tumors attenuate tissue damage without perturbation of miRNA activity","volume":"22","author":"Bofill-De Ros","year":"2014","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.virusres.2017.08.016_bib0015","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.bbadis.2011.02.002","article-title":"MicroRNAs and the cell cycle","volume":"1812","author":"Bueno","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"9","key":"10.1016\/j.virusres.2017.08.016_bib0020","doi-asserted-by":"crossref","first-page":"e73964","DOI":"10.1371\/journal.pone.0073964","article-title":"Anti-tumor activity of a miR-199-dependent oncolytic adenovirus","volume":"8","author":"Callegari","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.virusres.2017.08.016_bib0025","doi-asserted-by":"crossref","first-page":"e16152","DOI":"10.1371\/journal.pone.0016152","article-title":"MicroRNA controlled adenovirus mediates anti-cancer efficacy without affecting endogenous microRNA activity","volume":"6","author":"Cawood","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.virusres.2017.08.016_bib0030","first-page":"63","article-title":"Promising oncolytic agents for metastatic breast cancer treatment","volume":"4","author":"Cody","year":"2015","journal-title":"Oncolytic Virotherapy"},{"issue":"5","key":"10.1016\/j.virusres.2017.08.016_bib0035","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.3892\/ijo.2017.3945","article-title":"miR-145 inhibits proliferation and migration of breast cancer cells by directly or indirectly regulating TGF-beta1 expression","volume":"50","author":"Ding","year":"2017","journal-title":"Int. J. Oncol."},{"issue":"2","key":"10.1016\/j.virusres.2017.08.016_bib0040","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1158\/1541-7786.MCR-14-0251","article-title":"lincRNA-RoR and miR-145 regulate invasion in triple-negative breast cancer via targeting ARF6","volume":"13","author":"Eades","year":"2015","journal-title":"Mol. Cancer Res. MCR"},{"issue":"11","key":"10.1016\/j.virusres.2017.08.016_bib0045","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1002\/cncr.30547","article-title":"Treatment-associated toxicities reported by patients with early-stage invasive breast cancer","volume":"123","author":"Friese","year":"2017","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.virusres.2017.08.016_bib0050","doi-asserted-by":"crossref","first-page":"37","DOI":"10.5493\/wjem.v6.i2.37","article-title":"MicroRNA-regulated viral vectors for gene therapy","volume":"6","author":"Geisler","year":"2016","journal-title":"World J. Exp. Med."},{"issue":"2","key":"10.1016\/j.virusres.2017.08.016_bib0055","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/bab.1390","article-title":"An alternative approach in regulation of expression of a transgene by endogenous miR-145 in carcinoma and normal breast cell lines","volume":"64","author":"Ghanbari Safari","year":"2017","journal-title":"Biotechnol. Appl. Biochem."},{"issue":"Suppl. 15","key":"10.1016\/j.virusres.2017.08.016_bib0060","article-title":"Toxicity of extended adjuvant aromatase inhibitors therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis","volume":"35","author":"Goldvaser","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.virusres.2017.08.016_bib0065","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1128\/JVI.02933-14","article-title":"Coxsackievirus B3 engineered to contain microRNA targets for muscle-specific microRNAs displays attenuated cardiotropic virulence in mice","volume":"89","author":"He","year":"2015","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.virusres.2017.08.016_bib0070","doi-asserted-by":"crossref","first-page":"5647","DOI":"10.1128\/JVI.07125-11","article-title":"MicroRNA targeting of neurotropic flavivirus: effective control of virus escape and reversion to neurovirulent phenotype","volume":"86","author":"Heiss","year":"2012","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.virusres.2017.08.016_bib0075","doi-asserted-by":"crossref","first-page":"e21307","DOI":"10.1371\/journal.pone.0021307","article-title":"Use of microRNA Let-7 to control the replication specificity of oncolytic adenovirus in hepatocellular carcinoma cells","volume":"6","author":"Jin","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.virusres.2017.08.016_bib0080","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2174\/156800907780618301","article-title":"Conditionally replicating adenoviruses for cancer treatment","volume":"7","author":"Jounaidi","year":"2007","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.virusres.2017.08.016_bib0085","first-page":"480","article-title":"50% end-point calculation","volume":"162","author":"Karber","year":"1931","journal-title":"Arch. Exp. Pathol. Pharmakol."},{"issue":"3","key":"10.1016\/j.virusres.2017.08.016_bib0090","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/mt.2008.288","article-title":"MicroRNAs and the regulation of vector tropism","volume":"17","author":"Kelly","year":"2009","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.virusres.2017.08.016_bib0095","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/1743-422X-10-241","article-title":"MicroRNA-145 regulates oncolytic herpes simplex virus-1 for selective killing of human non-small cell lung cancer cells","volume":"10","author":"Li","year":"2013","journal-title":"Virol. J."},{"issue":"4","key":"10.1016\/j.virusres.2017.08.016_bib0100","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2217\/fvl-2016-0129","article-title":"Designing and building oncolytic viruses","volume":"12","author":"Maroun","year":"2017","journal-title":"Future Virol."},{"issue":"5","key":"10.1016\/j.virusres.2017.08.016_bib0105","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.eururo.2010.02.016","article-title":"Re: microRNA regulation of oncolytic herpes simplex virus-1 for selective killing of prostate cancer cells","volume":"57","author":"Schaefer","year":"2010","journal-title":"Eur. Urol."},{"issue":"10","key":"10.1016\/j.virusres.2017.08.016_bib0110","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2217\/fvl-2016-0069","article-title":"Selective replication of miR-145-regulated oncolytic adenovirus in MCF-7 breast cancer cells","volume":"11","author":"Shayestehpour","year":"2016","journal-title":"Future Virol."},{"issue":"3","key":"10.1016\/j.virusres.2017.08.016_bib0115","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12032-017-0899-0","article-title":"Oncolytic viruses: emerging options for the treatment of breast cancer","volume":"34","author":"Suryawanshi","year":"2017","journal-title":"Med. Oncol."},{"issue":"13","key":"10.1016\/j.virusres.2017.08.016_bib0120","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1158\/0008-5472.CAN-16-0359","article-title":"OncomiR or tumor suppressor? The duplicity of MicroRNAs in cancer","volume":"76","author":"Svoronos","year":"2016","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.virusres.2017.08.016_bib0125","first-page":"1461","article-title":"miR-145 inhibits breast cancer cell growth through RTKN","volume":"34","author":"Wang","year":"2009","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.virusres.2017.08.016_bib0130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.virol.2014.04.007","article-title":"The application of multiple miRNA response elements enables oncolytic adenoviruses to possess specificity to glioma cells","volume":"458","author":"Yao","year":"2014","journal-title":"Virology"},{"issue":"22","key":"10.1016\/j.virusres.2017.08.016_bib0135","doi-asserted-by":"crossref","first-page":"11009","DOI":"10.1128\/JVI.01608-08","article-title":"Generation of a conditionally replicating adenovirus based on targeted destruction of E1A mRNA by a cell type-specific MicroRNA","volume":"82","author":"Ylosmaki","year":"2008","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.virusres.2017.08.016_bib0140","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1158\/1535-7163.MCT-12-0157","article-title":"MicroRNA regulation of oncolytic adenovirus 6 for selective treatment of castration-resistant prostate cancer","volume":"11","author":"Zhang","year":"2012","journal-title":"Mol. Cancer Ther."},{"issue":"7","key":"10.1016\/j.virusres.2017.08.016_bib0145","first-page":"3106","article-title":"miR-145 suppresses breast cancer cell migration by targeting FSCN-1 and inhibiting epithelial-mesenchymal transition","volume":"8","author":"Zhao","year":"2016","journal-title":"Am. J. Transl. Res."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170217305439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170217305439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T14:05:50Z","timestamp":1759154750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170217305439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":29,"alternative-id":["S0168170217305439"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2017.08.016","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting human breast cancer cells by an oncolytic adenovirus using microRNA-targeting strategy","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2017.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}